HIKAL
Back to Balance Sheet
|
HIKAL Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹49 Cr | ₹35 Cr | ₹30 Cr | ₹30 Cr | ₹29 Cr |
What is the latest Contingent Liabilities ratio of HIKAL ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹49 Cr |
Mar2023 | ₹35 Cr |
Mar2022 | ₹30 Cr |
Mar2021 | ₹30 Cr |
Mar2020 | ₹29 Cr |
How is Contingent Liabilities of HIKAL Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹49 Cr | 41.22 | |
Mar2023 | ₹35 Cr | 17.23 | |
Mar2022 | ₹30 Cr | 0.00 | |
Mar2021 | ₹30 Cr | 1.70 | |
Mar2020 | ₹29 Cr | - |
Compare Contingent Liabilities of peers of HIKAL
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
HIKAL | ₹3,576.3 Cr | -7.8% | -14.7% | -9.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹380,702.0 Cr | -3.3% | -4.6% | -7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,908.0 Cr | -9% | -13.6% | 24% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,896.0 Cr | -1.1% | 7% | 8.2% | Stock Analytics | |
CIPLA | ₹119,988.0 Cr | -2% | 0.6% | -4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,122.0 Cr | -1.1% | -3.8% | -13.3% | Stock Analytics |
HIKAL Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
HIKAL | -7.8% |
-14.7% |
-9.1% |
SENSEX | -0.9% |
-4.4% |
1.6% |
You may also like the below Video Courses